Jan 9, 2009 07:10 PM in Health & Medicine | Post a comment
Influenza drug Tamiflu ineffective against most U.S. infection
By Jordan Lite
Tamiflu, an antiviral used to treat the flu, doesn’t work against most of the virus circulating in the U.S. this season, federal officials say.
It's not a serious problem so far, because fewer than the usual number of people have caught the flu this year, U.S. Centers for Disease Control and Prevention (CDC) authorities say. But 99 percent of cases this year are resistant to the drug, compared to 11 percent last year, The New York Times reports.
The resistance seems to stem from a spontaneous mutation in the virus, not the result of overuse of the drug, according to the Times. They've advised patients to use a Tamiflu rival, Relenza, or an older med called rimantadine, according to Bloomberg News.
For more on why viruses become resistant to medications thanks to evolution—and the prospect of performing DNA analyses of an infection to decide how best to treat it—check out this article in this month's Scientific American.
Image of Tamiflu by Moriori via Wikimedia Commons
Read More About: flu, influenza, CDC, tamifluYou Might Also Like
Discuss This Article
Subscription Center
Most Popular Blog Posts
9,000-year-old brew hitting the shelves this summer
New solar-cell efficiency record set
AIDS vaccine surprises scientists, proves partially successful
Is birth control the answer to environmental ills?
Editor's Pick
-
Adapting to the Freshwater CrisisForward-thinking experts are getting a better handle on the growing global water shortage and coming up with innovative approaches to ensuring the security, safety and sustainability of this resource
Health & Medicine Newsletter
Get weekly coverage delivered to your inboxPodcasts
-
60-Second Earth
RSS ·
iTunes
The Jellyfish Menace
click to enable
-
60-Second Science
RSS ·
iTunes
Plants Share Light If Neighbor Is Related
click to enable
Slideshows
Researchers Try to Solve the Mystery of HIV Carriers Who Don't Contract AIDS
Putting Madness in Its Place: Can the Environment Explain Schizophrenia's Hereditary Patterns?
War Is Peace: Can Science Fight Media Disinformation?
Fight to protect California condors from lead ammunition moves to Arizona
Circulation of LHC Beams Could Resume in Earnest over the Weekend
Measuring Up: New NIST Director, Plus Big Budget Put Measurement Science in Public Eye
How Long Can a Nuclear Reactor Last?
What to Do About Endocrine Disruptors? A Q&A with Linda Birnbaum



